Position in PBH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,707,559
-$6,332,381 QoQ
Shares Held
184,209
-27.4% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#51
of 316 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $144,607,995 across 17 Drug Manufacturers - Specialty & Generic names. PBH ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
6,652,349 | $62,066,416 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
567,585 | $19,229,779 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
60,224 | $10,150,152 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
17,340 | $9,395,332 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
184,209 | $8,707,559 | |
| 6 | VTRS |
Viatris Inc
|
472,511 | $7,503,474 | |
| 7 | ZTS |
Zoetis Inc.
|
96,209 | $6,913,578 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
268,328 | $4,301,297 |
All Filings in PBH
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,707,559 | 184,209 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,039,940 | 253,753 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,681,171 | 237,983 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $13,515,777 | 216,599 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $22,996,480 | 287,996 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,897,750 | 208,186 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $16,340,020 | 209,246 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $1,051,290 | 14,581 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $901,246 | 13,090 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $1,012,719 | 13,957 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $763,903 | 12,478 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $662,031 | 11,576 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $948,656 | 15,147 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $839,153 | 13,405 | Shares | Defined | 2023-01-27 | |
| 2022-06-30 | $879,883 | 14,964 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $554,546 | 10,475 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $684,313 | 11,283 | Shares | Defined | 2022-02-08 | |
| 2020-12-31 | $3,098,827 | 88,868 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,115,767 | 85,551 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,277,110 | 87,250 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,807,127 | 103,793 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||